Access count of this item: 117

Files in This Item:
File Description SizeFormat 
31_365.pdf388.08 kBAdobe PDFView/Open
Title: 複雑性尿路感染症に対するCefmenoxime (CMX)の臨床的検討
Other Titles: Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection
Authors: 土田, 正義  KAKEN_name
佐々木, 秀平  KAKEN_name
高田, 斉  KAKEN_name
宮形, 滋  KAKEN_name
佐藤, 貞幹  KAKEN_name
清水, 世紀  KAKEN_name
坂本, 文和  KAKEN_name
木津, 典久  KAKEN_name
Author's alias: TSUCHIDA, Seigi
SASAKI, Shuhei
TAKADA, Hitoshi
SATO, Sadamoto
SAKAMOTO, Fumikazu
KIZU, Norihisa
Keywords: Complicatedu rinary tract infection
C efmenoximeC
Issue Date: Feb-1985
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 31
Issue: 2
Start page: 365
End page: 374
Abstract: 1回2 g, 1日2回の点滴静注を5日間連用し,解析対象となし得た29例についての総合臨床効果は,著効1,有効15,無効13例であった.そのうち,カテーテル留置例14例の有効率50%,非留置例15例の有効率は60%であった.菌消失率は35株中27株(77.1%)であった.副作用としては1例に軽度下痢を認めたほか臨床検査で血清トランスアミナーゼの上昇4例,血清クレアチニンの上昇2例を認めた
Cefmenoxime (CMX), a new semisynthetic antibiotic, was administrated in 29 cases diagnosed as complicated urinary tract infection. All patients received drip injection of 2 g (twice a day) for 5 days. Clinical results were excellent in 1 patient (3.4%), good in 15 patients (51.8%) and poor in 13 patients (44.8%). Effectiveness rate was 55.2%. In bacteriological response, out of 35 strains 27 (77.1%) strains were eradicated and 8 (22.9%) strains persisted. As for side effects, except one case of transient diarrhea after administration, no noteworthy reactions were observed. Laboratory abnormalities attributed to CMX treatment consisted of 4 cases of elevated serum transaminase and 2 cases of elevated serum creatinine.
PubMed ID: 3859998
Appears in Collections:Vol.31 No.2

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.